Kumho P&B Chemicals. Inc Overview
Kumho P&B Chemicals is Korea's original, and still one of its two largest, integrated producers of phenol, acetone and bisphenol-A (BPA). It runs a single, highly integrated complex in the Yeosu National Industrial Complex. Nameplate capacity totals 2.85 million tonnes per year: cumene (900 kt), phenol (680 kt), acetone (420 kt), BPA (450 kt), epoxy resin (338 kt) and MIBK (60 kt). The parent ranks KPB as the world's fifth-largest BPA maker and ninth-largest phenol maker. Its strategic distinction is vertical integration from propylene/benzene-derived cumene through phenol/acetone to BPA and then epoxy resins, plus an upstream bio-epichlorohydrin (ECH) joint venture in Malaysia. KPB sells into polycarbonate, coatings, wind-blade composites, electronics, construction and solvents markets, and exports heavily. Earnings are highly cyclical. The segment it underpins went from a KRW 1.0 trn operating profit in 2021 to losses in 2024–2025, then returned to profit in 2Q26.
Company's own description
The parent's FY2025 business report describes KPB in these terms (paraphrased). KPB specialises in producing and selling BPA, phenol, acetone, MIBK and epoxy resins, which are core materials for construction, shipbuilding, automotive, electrical/electronics, pharmaceuticals and coatings. It began in 1976 as Korea's only phenol and acetone producer. It has since grown, through technology development and successive expansions, into a petrochemical company competitive at international scale.
The group's affiliate page adds the global rankings: 5th-largest BPA producer (450 kt/yr) and 9th-largest phenol producer worldwide. It also notes that BPA is the key raw material for polycarbonate used in appliances, phones and auto parts.
Independent characterisation
KPB is a mid-stream commodity-to-semi-specialty aromatics derivatives producer. Its economics are driven by:
Feedstock spreads: Benzene and propylene go into cumene, then phenol + acetone (cumene process), then BPA (phenol + acetone), then epoxy (BPA + ECH).
Co-product balance: The cumene process yields roughly 0.6 t of acetone per tonne of phenol, so acetone pricing materially affects cash margins. MIBK is an acetone-upgrading outlet.
Chinese capacity cycles: Since 2021, China's large self-sufficiency build-out in phenol/BPA has compressed Asian margins. This is the main structural headwind behind the 2023–2025 losses.
Trade remedies: China (phenol and BPA, 2019), the US (epoxy, 2025) and India (liquid epoxy resin, 2025) have imposed anti-dumping measures that cover or name KPB.
Business model and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | ~100% product sales (bulk chemicals and resins), sold on spot, contract and formula pricing. Small tolling/consignment arrangements exist (e.g., HBPA made by the parent from KPB's BPA). No subscription or licensing revenue has been disclosed. |
| Value-chain position | Integrated mid-stream: cumene → phenol/acetone → BPA → epoxy; MIBK from acetone; AMS (alpha-methylstyrene) by-product. |
| Captive vs merchant | Cumene is largely captive. Phenol, MIBK and AMS are partly sold to the parent (the parent's subsidiary register lists purchases of "Phenol, MIBK, AMS" from KPB). BPA is partly captive to epoxy. The remainder of BPA goes to merchant buyers (polycarbonate makers, epoxy makers). |
| Customer types | Polycarbonate producers; epoxy formulators and coatings companies; composites/wind-blade fabricators; phenolic resin, adhesive, pharmaceutical and solvent users; related parties (Kumho Petrochemical, D&K Chemtech). |
| End markets | Electronics/electrical, automotive, construction and insulation, marine and protective coatings, wind energy, pharmaceuticals, paints and solvents. |
| Geographic model | Export-heavy (exact split not disclosed for KPB). Evidence of material exposure to China, the US, India and Europe comes from trade-remedy cases and the 2025 creation of a European subsidiary. |
Strategy
Stated strategy themes
Group level (Kumho Petrochemical FY2024 and FY2025 Business Reports):
-
2025 management motto: "Act Ahead".
-
2026 motto: "Strengthen core competitiveness & convert to a profit-making structure". The stated goal is to lay the foundation for every division to be profitable, which is directly aimed at loss-making units such as KPB.
-
Three medium-term growth pillars: (1) eco-friendly automotive solutions; (2) bio and sustainable materials; (3) faster transition to high-value specialty products, including related M&A.
-
2026 company-wide strategy: strengthen high-value products on a profitability basis; restructure and streamline low-return products; accelerate sustainability management.
-
The CEO's FY2025 letter warns that Korean petrochemicals face "the most intense restructuring in history" in 2026.
KPB-specific themes (FY2024–FY2025 reports and press):
-
Use vertical integration from phenol/acetone through BPA to epoxy as the competitive core.
-
Keep expanding epoxy capacity and develop high-value epoxy using in-house know-how.
-
Secure raw-material stability through bio-ECH.
-
Build an eco-epoxy portfolio (solvent-free, water-borne, bio-based low-carbon) for construction, marine and flooring.
-
Extend into building materials via PF insulation, broadening from external to internal flame-retardant insulation in 2026.
Initiative register (last ~24 months plus anchors)
| Initiative | Type | Status | Target / Metric |
|---|---|---|---|
| Epoxy +60 kt expansion | Capacity | Completed 2Q24 | Total 338 kt |
| OCIKumho bio-ECH (Malaysia) | Upstream JV / ESG | Construction; further equity in FY2025 | 100 kt ECH; ≥70% offtake to KPB |
| HBPA expansion | Specialty product | "Expanding" (FY2024 BR) | Initial 5 kt |
| Eco-epoxy (solvent-free, water-borne, bio-based) | R&D / product | Ongoing | Not quantified |
| D&K Chemtech PF board, internal insulation launch | Downstream diversification | 2026 product extension | Return to profitability not yet achieved |
| Kumho P&B Chemicals Europe GmbH | Commercial footprint | Established FY2025 | — |
| Parent "Value-Up" plan (11 Feb 2025) | Capital allocation | Active | 6% revenue growth to 2030; ROE 7% by 2026 and 10% by 2030; shareholder return up to 40% of separate net income |
| Restructuring of low-return businesses (parent 2026) | Portfolio | Announced intent | Not KPB-specific; no closure announced |
Medium-term targets / guidance
KPB publishes no financial guidance. Parent segment outlook statements:
-
For 1Q26: narrower losses as demand rises.
-
For 2Q26: earnings improvement as product prices rise, despite maintenance.
-
For 3Q26: seasonal weakness and softer downstream demand in parts of the business (segment not specified).
Products & Services
All production is at the Yeosu complex unless noted. Capacities are from the Kumho Petrochemical 1Q26 IR deck (unchanged since at least 4Q24).
Pricing model. Not disclosed. Industry practice for phenol/acetone/BPA is contract formulas indexed to benzene/propylene plus spot-assessed premia (ICIS, Platts). Epoxy is sold on negotiated contract and spot terms.
Product Portfolio
| Product | Capacity (t/yr) | Description & chemistry | Key end uses / target customers | Latest disclosed development |
|---|---|---|---|---|
Cumene | 900,000 | Benzene + propylene alkylation; intermediate for phenol/acetone | Mostly captive feed to the phenol units | KPA (IV) completed 2016 (420 kt → 900 kt) |
Phenol | 680,000 | Cumene oxidation/cleavage | BPA (captive and merchant), phenolic resins, caprolactam/nylon, alkylphenols, pharmaceuticals; sold in part to Kumho Petrochemical | POSCO E&C cites 700 kt post-2016; IR deck says 680 kt (discrepancy noted) |
Acetone | 420,000 | Co-product of the cumene process | BPA, MIBK, MMA, solvents, pharmaceuticals | POSCO E&C cites 435 kt post-2016; IR deck says 420 kt |
BPA (bisphenol-A) | 450,000 | Phenol + acetone condensation | Polycarbonate (appliances, phones, auto parts), epoxy resins (captive) | 5th-largest globally per parent; BPA maintenance weighed on 4Q25 |
MIBK | 60,000 | Acetone-derived solvent/intermediate | Coatings solvents, rubber antioxidant (6PPD) precursors; sold in part to the parent | — |
Epoxy resins | 338,000 | BPA + ECH; liquid, solid, solution and specialty grades; systems for wind-turbine blades | Protective/marine coatings, construction and flooring, electronics, composites, wind blades | 60 kt expansion completed 2Q24 |
Eco-epoxy line (solvent-free, water-borne, bio-based low-carbon) | — | Next-generation epoxy formulations | Construction, marine, flooring under tighter VOC/carbon rules | Highlighted as an R&D focus in KKPC FY2025 Business Report |
HBPA (hydrogenated BPA) | 5,000 (at parent's plant) | BPA hydrogenated for better heat, weather and yellowing resistance; KPB supplies BPA, the parent hydrogenates under contract, KPB sells or uses the HBPA | High-performance epoxy, PC, surfactants | Announced June 2022; production from 2H23; "expanding" per FY2024 report |
AMS (alpha-methylstyrene) | — | Cumene-process by-product | Sold to Kumho Petrochemical (resins/rubber) | Related-party flow listed in parent register |
Bio-ECH (via OCIKumho, 50%) | 100,000 (JV capacity) | Glycerine-to-ECH route using hydro-powered electricity | Captive epoxy feedstock; KPB offtake ≥70% | EPC awarded Dec 2023; 20-month build (completion and start-up date not confirmed in sources reviewed) |
PF (phenolic foam) insulation board (via D&K Chemtech, 50%) | — | Phenolic-foam insulation boards (marketed under the HuGreen insulation line) | Construction insulation; moving from external to internal flame-retardant boards in 2026 | Commercial since Sep 2023; loss-making |
Financial Narrative
Data availability statement
Because KPB is unlisted, its full income statement, balance sheet and cash flow are filed only as an external-audit report on DART (Korea's FSS electronic disclosure system). The tables below use the segment proxy (6.2), entity-level disclosures (6.3) and parent context (6.4). The following are not publicly disclosed in the sources reviewed for KPB stand-alone: gross profit, EBITDA, pre-tax income, EPS, DPS, total assets, cash, debt (short/long), net debt, equity, goodwill and intangibles, working capital, operating cash flow, capex, FCF, dividends paid to the parent, ROE/ROA/ROIC, current ratio, D/E, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle.
Income-statement proxy: Phenol Derivatives segment
Revenue CAGR FY2021–FY2025: −12.1% per year (KRW 2,689 bn → 1,607.5 bn). Peak-to-trough operating profit swing: KRW −1,046 bn.
Trend commentary
FY2021 (super-cycle peak). Pandemic-era demand for polycarbonate (electronics, medical devices) and epoxy, combined with Western supply outages, drove BPA and epoxy spreads to historic highs. The segment earned a 37.5% operating margin, about 42% of the group's record KRW 2.4 trn operating profit. Bizwatch (May 2021) singled out the BPA/epoxy segment as the group's fastest-growing earnings line at the time.
FY2022 (rapid normalisation). Revenue fell 18% and operating profit 70%. Contemporaneous disclosures attribute this to weaker polycarbonate demand, new Chinese BPA capacity (4Q21 commentary), China's COVID lockdowns and spread compression (2Q22 commentary, where segment OP fell 70% YoY to KRW 98.6 bn).
FY2023 (trough by revenue). Revenue fell a further 31% and the segment broke even (KRW 3 bn OP). In 1Q23 the company cited BPA oversupply and weak demand: segment revenue fell 35% YoY and OP 93% YoY.
FY2024 (volume up, margin down). Revenue recovered 8% on volumes, but heavy maintenance in 4Q24 and spread compression produced a KRW −22.2 bn quarterly loss and a small full-year loss. The 60 kt epoxy expansion came on stream in 2Q24, but the epoxy market was weak.
FY2025 (loss widens). Revenue was flat to down. Losses deepened in 2H25: 3Q −14.4, 4Q −22.3 (BPA maintenance and delayed demand recovery). At entity level, KPB booked a KRW −45.0 bn net loss, its third consecutive annual loss according to Dealsite (June 2026).
1H26 (inflection). In 1Q26 the loss narrowed (−8.6) as early-year restocking and March stockpiling linked to the Middle East war improved spreads. In 2Q26 the segment swung to KRW +55.1 bn (11.2% margin) despite maintenance-reduced volumes, as customers secured product amid supply disruption (Sidae/Dealsite, 7 Aug 2026). This is the strongest quarterly result since FY2022. The driver appears to be exogenous supply shock rather than structural repair, a key point for Section 22.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Investee Details
| Investee | Stake | Business | Source |
|---|---|---|---|
Kumho Development Trading Co. (금호개발상사) | 100% | Trading; owns Kumho Green Bio Busan and Kumho Green Bio Changwon (100% each) | KKPC FY2025 BR |
Kumho P&B Chemicals Europe GmbH | 100% (25,000 shares) | European sales subsidiary (new in FY2025) | KKPC FY2025 BR |
D&K Chemtech Co. (㈜디앤케이켐텍) | 50% (3,000,000 shares, up from 2,520,000 in FY2024) | Phenolic-foam (PF) insulation board, JV with Dongsung Chemical | KKPC FY2024/25 BR; Dealsite |
Jiangsu Kumho Yangnong Chemical Co. (강소금호양농화공) | 50% | China-based chemical JV (product scope not disclosed in sources reviewed) | KKPC FY2025 BR |
OCIKumho Sdn. Bhd. | 50% (332.0 M shares, up from 270.8 M) | Bio-ECH, Samalaju, Malaysia | KKPC FY2025 BR |
Kumho Resort Co. | 33.28% (parent holds 66.72%) | Leisure/condominiums/golf | KKPC FY2025 BR |
Yeosu Petro Co. | 20.20% | Petrochemical jetty and piping logistics | KKPC FY2025 BR |
Korea Impact Scale-up Investment Fund | 12% | Impact VC fund | KKPC FY2025 BR |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Phenol Derivatives revenue (KRW Bn) | 2,689 | 2,202 | 1,514 | 1,635.2 | 1,607.5 |
Phenol Derivatives operating profit (KRW Bn) | 1,009 | 306 | 3 | -17.9 | -37.1 |
Phenol Derivatives operating margin (%) | 37.5 | 13.9 | 0.2 | -1.1 | -2.3 |
Revenue growth YoY (%) | 0 | -18.1 | -31.2 | 8.0 | -1.7 |
Share of group revenue (%) | 31.8 | 27.6 | 23.9 | 22.9 | 23.2 |
Share of group operating profit (%) | 41.9 | 26.7 | 0.8 | -6.6 | -13.6 |
Segment Revenue
| Metric | 1Q24 | 2Q24 | 3Q24 | 4Q24 | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 398.8 | 444.4 | 406.5 | 385.5 | 431.7 | 432.6 | 378.7 | 364.5 | 399.2 | 492.8 |
Operating profit (KRW Bn) | -2.5 | 5.7 | 1.1 | -22.2 | 1.9 | -2.3 | -14.4 | -22.3 | -8.6 | 55.1 |
Operating margin (%) | -0.6 | 1.3 | 0.3 | -5.8 | 0.4 | -0.5 | -3.8 | -6.1 | -2.2 | 11.2 |
Results by Segment
| Metric | FY2024 | FY2025 |
|---|---|---|
Revenue (KRW Bn) | 1,665.3 | 1,641.4 |
Net income (KRW Bn) | 8.7 | -45.0 |
Operating income (KRW Bn) | — | -37.1 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 2,689 | 2,202 | 1,514 | 1,635.2 | 1,607.5 |
Operating profit (KRW Bn) | 1,009 | 306 | 3 | -17.9 | -37.1 |
Operating margin (%) | 37.5 | 13.9 | 0.2 | -1.1 | -2.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (FY2024–FY2025)
| Metric | FY2024 | FY2025 |
|---|---|---|
Revenue (KRW Bn) | 1,665.3 | 1,641.4 |
Net income (KRW Bn) | 8.7 | -45.0 |
Net margin (%) | 0.5 | -2.7 |
Revenue growth YoY (%) | 0 | -1.4 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 8,461.8 | 7,975.6 | 6,322.5 | 7,155.0 | 6,915.1 |
Operating profit (KRW Bn) | 2,406.8 | 1,147.3 | 359.0 | 272.8 | 271.8 |
Net income to owners (KRW Bn) | 1,973.7 | 1,019.9 | 446.8 | 348.6 | 290.9 |
Total assets (KRW Bn) | — | 7,717.4 | 7,979.7 | 8,340.2 | 8,474.5 |
Total equity (KRW Bn) | — | 5,679.3 | 5,834.0 | 6,042.2 | 6,246.5 |
Cash & equivalents (KRW Bn) | — | 567.3 | 452.4 | 429.3 | 650.4 |
Operating cash flow (KRW Bn) | — | — | 630.7 | 322.3 | 715.3 |
Capex (PP&E acquisition, KRW Bn) | — | — | 589.8 | 436.2 | 194.4 |
Financial Analysis
| Metric | 1Q26 | 2Q26 | 1H26 |
|---|---|---|---|
Phenol Derivatives revenue (KRW Bn) | 399.2 | 492.8 | 892.0 |
Phenol Derivatives OP (KRW Bn) | -8.6 | 55.1 | 46.5 |
Group revenue (KRW Bn) | 1,780.0 | 2,268.2 | 4,048.2 |
Group OP (KRW Bn) | 59.4 | 339.0 | 398.4 |
Revenue by Region (%)
| Region | FY2024 | FY2025 |
|---|---|---|
Asia ex-China (%) | 51.4 | 45.9 |
China (%) | 23.4 | 25.2 |
North America (%) | 9.9 | 11.6 |
Europe (%) | 9.7 | 11.4 |
Africa (%) | 3.8 | 3.8 |
South America (%) | 1.2 | 1.4 |
Oceania (%) | 0.7 | 0.7 |
Revenue by Region
| Metric | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
US imports from Korea, value (USD Mn) | 337.8 | 488.5 | 204.6 |
US imports from Korea, volume (M lbs) | 149.8 | 184.0 | 124.7 |
Region Overview
| Region | Evidence of KPB exposure | Direction |
|---|---|---|
China | China has levied anti-dumping duties on Korean phenol (from 6 Sep 2019) and BPA (continued from 30 Aug 2019), with KPB individually named in both MOFCOM rulings. Massive Chinese self-sufficiency additions. | Declining: tariffs plus import substitution |
United States | Korea was the largest foreign source of US epoxy imports in 2021–2023 (above). AD (7.59% cash deposit) and CVD (1.84%) orders apply to KPB from May 2025. | Pressured: order in force; Korean imports fell 58% in value from 2022 to 2023, before the order |
India | India's liquid epoxy resin anti-dumping duty (Nov 2025, 5 years) covers Korea. An earlier Indian phenol order set a nil duty for KPB-produced phenol exported through named Korean traders (Humade, Woori P&C, Canko). | Mixed: phenol access preserved, epoxy access curtailed |
Europe | Kumho P&B Chemicals Europe GmbH set up in FY2025. Lotte Fine Chemical's research notes EU anti-dumping on Chinese epoxy redirecting demand to other Asian suppliers. | Growing (by inference, not quantified) |
Korea (domestic) | Captive and related-party sales (Kumho Petrochemical, D&K), Korean polycarbonate and epoxy makers | Stable base |
Share Price and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price (KRW) | 166,000 | 126,000 | 132,900 | 90,600 | 120,700 |
Dividend per common share (KRW) | 10,000 | 5,400 | 2,900 | 2,200 | 1,700 |
Separate-basis EPS (KRW) | 35,370 | 21,097 | 11,340 | 9,972 | 6,820 |
Separate-basis ROE (%) | 37.8 | 18.5 | 9.5 | 8.0 | 5.1 |
Bond Details
| Bond | Issue date | Amount (KRW Bn) | Coupon (%) | Maturity |
|---|---|---|---|---|
155-1 | 5 Apr 2024 | 45 | 3.969 | 3 Apr 2026 |
155-2 | 5 Apr 2024 | 55 | 4.003 | 5 Apr 2027 |
156-1 | 9 Jun 2025 | 60 | 3.039 | 9 Jun 2028 |
156-2 | 9 Jun 2025 | 40 | 3.311 | 7 Jun 2030 |
Analyst Conclusions
Management guidance
KPB gives no guidance. The parent's most recent qualitative outlook (2Q26 release) expects some businesses to soften in 3Q26 on seasonality and slower downstream demand, while energy improves. Phenol Derivatives was not singled out. The 2026 group mandate is to establish profitability in every division.
Consensus
No consensus exists for KPB. The latest retrieved sell-side estimate (Kiwoom, Nov 2025) had near break-even segment OP for FY2026 (KRW +0.8 bn). Actual 1H26 OP of KRW +46.5 bn implies upside revisions are likely, but they are not yet documented in sources reviewed.
Bull case
-
Operating leverage is real. A 492.8 bn quarter at an 11.2% margin shows how much the 680 kt phenol / 450 kt BPA base can earn when spreads widen. If 3Q–4Q26 hold even half of 2Q26's profitability, FY2026 segment OP could be the best since FY2022.
-
Supply-side rationalisation. Korean government-led restructuring, possible LG Chem BPA exit (unconfirmed), and trade-remedy walls against Chinese material in the US, EU and India could improve KPB's relative position in non-China markets, where its US duty rates are moderate.
-
Margin-mix upgrade. Bio-ECH integration, HBPA and eco-epoxy, plus a European sales platform, give a credible route from commodity BPA toward higher-value epoxy systems.
Bear case
-
The 2Q26 rebound is shock-driven. The company attributes it to customer stockpiling amid war-related supply concerns. Once inventories normalise, the 2023–25 pattern (margins of −6% to +1%) could return.
-
Structural market loss. China's self-sufficiency, plus US (7.59% + 1.84%) and Indian duties on epoxy, shrink KPB's addressable export markets while capacity elsewhere keeps growing at more than 3% per year.
-
Capital drag from adjacencies. D&K Chemtech's KRW 49 bn cumulative losses and further equity injections in FY2025 dilute returns. Under the parent's value-up framework, persistent losses risk forced downsizing rather than growth funding.
Key catalysts and monitorables (next 12 months)
| # | Monitorable | Why it matters |
|---|---|---|
| 1 | Parent 3Q26 results (~early Nov 2026): Phenol Derivatives OP | Tests whether 2Q26 was a one-off |
| 2 | Asian BPA–phenol and epoxy–BPA spreads | Primary earnings driver |
| 3 | OCIKumho bio-ECH start-up date and utilisation | Feedstock integration and ESG premium |
| 4 | Korean petrochemical restructuring outcomes; LG Chem BPA transaction | Domestic supply structure |
| 5 | US AD/CVD first administrative review; Indian duty implementation | Export access |
| 6 | D&K Chemtech performance after the internal-insulation launch | Whether the diversification strategy is validated or abandoned |
| 7 | KPB FY2026 stand-alone result (Mar 2027 business report) | Exit from three consecutive loss years |
| 8 | Parent capital allocation and any "low-return business" actions | Strategic tail risk for KPB |
Concluding analyst verdict
Kumho P&B Chemicals is a scale-advantaged but strategically squeezed asset. On physical metrics it is world-class: the 900 kt cumene train feeds 680 kt of phenol and 450 kt of BPA, and that BPA feeds 338 kt of epoxy, all on one integrated Yeosu site, earning top-ten global rankings in both phenol and BPA. Financially, it is one of the most cyclical earnings streams in Korean chemicals. Its segment proxy went from a KRW 1.0 trillion operating profit (37.5% margin) in FY2021 to three consecutive years of near-zero or negative returns. FY2025 ended with a KRW 45 bn stand-alone net loss.
The causes are mainly structural. China's capacity build-out and the trade remedies that followed in China, the US and India have closed or taxed the markets that once absorbed Korean surplus. Management's response has been sensible in direction but, so far, insufficient in scale or speed. Bio-ECH integration, specialty epoxies and HBPA are coherent moves up the value chain. The PF-board venture has so far consumed capital without returns.
The 2Q26 swing to an 11.2% margin is important as proof of operating leverage, but the company itself attributes it to war-related stockpiling, not repaired fundamentals. Our assessment is therefore "cyclical recovery, structural caution." Near-term earnings are likely to look far better than the 2023–25 trough. Durable value creation requires three things: (i) the bio-ECH JV running at scale, (ii) a demonstrable shift in mix toward specialty epoxy and non-China markets, and (iii) discipline over loss-making adjacencies under the parent's ROE-driven value-up framework.
For counterparties, KPB's credit standing rests mainly on its parent's very strong balance sheet. For strategic observers, the next four quarterly prints, starting with 3Q26, will show whether 2026 marks a new floor or a temporary spike.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Age | Compensation |
|---|---|---|---|---|---|
Lee Jeong-bok (이정복) | CEO (대표이사) | Since Jan 2024 | Korea University, Chemical Engineering. Joined Kumho Shell Chemical 1988; KPB Strategic Planning team (1998); director for expansion and purchasing; executive for planning and purchasing; EVP for planning and new business. Regarded as close to Chairman Park Chan-koo; championed the PF-board insulation business. | — | — |
Shin Woo-sung (신우성) | Former CEO | In office at least Dec 2021–Jun 2022; succeeded Jan 2024 | Signed the OCI bio-ECH JV (2021) and led the HBPA launch (2022) | — | — |
Baek Jong-hoon (백종훈) | Registered inside director of KPB; President & CEO of Kumho Petrochemical | KKPC CEO since 2021–22 | Pusan National Univ. Chem. Eng. (1986). Joined Kumho Shell 1988; Shell R&D in Japan and Belgium; KPB epoxy, phenol/solvent and overseas sales leadership (1996–2007); KKPC EVP Sales (2015). Born Sep 1961. | 64–65 | Not disclosed at KPB level |
Park Jun-kyung (박준경) | Registered inside director of KPB; President of Kumho Petrochemical | KKPC board since 2022; term to Mar 2028 | Son of Chairman Park Chan-koo; largest individual shareholder of KKPC (7.51%). Born Apr 1978. | 48 | Not disclosed at KPB level |
Park Chan-koo (박찬구) | Chairman, Kumho Petrochemical Group (ultimate controlling shareholder) | Long-standing | Group chairman; received KMAC "Best CEO" award in Dec 2024 | — | Not publicly disclosed for KPB |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Stake in KPB |
|---|---|
Kumho Petrochemical Co., Ltd. | 100.00% |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Jan 2024 | Lee Jeong-bok becomes CEO | Strategy pivot toward downstream building materials (PF board) and eco-epoxy |
Jun 2026 | Media scrutiny of CEO position | Dealsite reports D&K Chemtech's six-year cumulative net loss of KRW 49 bn and three consecutive loss years at KPB since Lee's appointment |
Competitive Landscape
Competitors by Segment
| Product | Named competitors | Notes |
|---|---|---|
Phenol / acetone | LG Chem (Korea); Mitsui Chemicals (Japan/Singapore); INEOS Phenol (EU/US); Formosa Chemicals & Fibre (Taiwan); PTT Phenol (Thailand); Chang Chun (Taiwan); Chinese producers (e.g., Zhejiang Petrochemical, Wanhua, Sinopec-Mitsui) | GlobalData: China, US, Korea, Taiwan and Germany held more than 68% of 15.65 mtpa global capacity in 2022 |
BPA | LG Chem; Mitsui Chemicals; Covestro; Nan Ya Plastics; Chang Chun; Chinese producers | MOFCOM's 2019 BPA review named Mitsui Chemicals and KPB among respondents |
Epoxy resins | Kukdo Chemical (Korea; global #1 by capacity); Nan Ya Plastics and Chang Chun (Taiwan); Olin and Westlake (US); Aditya Birla Chemicals (Thailand); Atul (India); Chinese producers (e.g., Jiangsu Sanmu, Shandong Bluestar Dongda) | All named in the 2024–25 US AD/CVD case |
ECH (adjacent) | Lotte Fine Chemical; Chinese ECH producers | OCIKumho entering |
MIBK | Global solvent producers (not individually verified) | — |
Peer Comparison FY2025
| Metric | KPB (stand-alone) | Kukdo Chemical | Kumho Petrochemical (consolidated parent) |
|---|---|---|---|
Revenue (KRW Bn) | 1,641.4 | 1,395.6 | 6,915.1 |
Revenue growth YoY (%) | -1.4 | 16.3 | -3.4 |
Operating margin (%) | -2.3 | 3.8 | 3.9 |
Recent Developments
The register is complete to the extent of available public information.*
